Laskawi R, Ellies M, Arglebe C, Schott A
Department of ENT, University of Göttingen, Germany.
J Oral Maxillofac Surg. 1995 May;53(5):506-8; discussion 509. doi: 10.1016/0278-2391(95)90057-8.
This retrospective study evaluated data pertaining to history, symptoms, diagnosis, and mode of therapy of patients treated for benign tumors of the submandibular gland.
The records of 38 patients were reviewed. The patients were divided into three groups: pleomorphic adenoma (first operation), pleomorphic adenoma (second operation for recurrence), and other tumors. Follow-up was done by questionnaires sent to the patient and referring doctor.
The vast majority of patients treated (92%) had had either a first or second operation for pleomorphic adenoma. Follow-up revealed that recurrence did not develop in the group of patients with primary surgery. However, one patient undergoing surgery for recurrent pleomorphic adenoma developed two recurrences. Two patients suffered from slight weakness of the lower lip.
Tumor recurrence was found only in the cases of second operation after previous surgery for pleomorphic adenoma. Therefore, the first operation should extirpate the entire gland to minimize the risk of recurrence.
本回顾性研究评估了与接受下颌下腺良性肿瘤治疗的患者的病史、症状、诊断及治疗方式相关的数据。
回顾了38例患者的记录。患者被分为三组：多形性腺瘤（首次手术）、多形性腺瘤（复发二次手术）及其他肿瘤。通过向患者及转诊医生发送问卷进行随访。
接受治疗的绝大多数患者（92%）因多形性腺瘤接受了首次或二次手术。随访显示，接受初次手术的患者组未出现复发。然而，1例接受复发性多形性腺瘤手术的患者出现了两次复发。2例患者下唇轻度无力。
仅在先前接受多形性腺瘤手术的二次手术病例中发现肿瘤复发。因此，首次手术应切除整个腺体，以将复发风险降至最低。
